Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 572

1.

Osteoconductive potential of a hydroxyapatite fiber material with magnesium: In vitro and in vivo studies.

Kozuma W, Kon K, Kawakami S, Bobothike A, Iijima H, Shiota M, Kasugai S.

Dent Mater J. 2019 Jun 29. doi: 10.4012/dmj.2018-333. [Epub ahead of print]

2.

Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer.

Kashiwagi E, Imada K, Monji K, Takeuchi A, Shiota M, Inokuchi J, Tatsugami K, Eto M.

Andrologia. 2019 Jun 23:e13354. doi: 10.1111/and.13354. [Epub ahead of print]

PMID:
31230398
3.

The Role of Nuclear Receptors in Prostate Cancer.

Shiota M, Fujimoto N, Kashiwagi E, Eto M.

Cells. 2019 Jun 17;8(6). pii: E602. doi: 10.3390/cells8060602. Review.

4.

Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer.

Shiota M, Kobayashi T, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Eto M.

Urol Oncol. 2019 Jun 12. pii: S1078-1439(19)30153-X. doi: 10.1016/j.urolonc.2019.04.020. [Epub ahead of print]

PMID:
31202731
5.

Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer.

Kobayashi T, Namitome R, Hirata YU, Shiota M, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Eto M.

Anticancer Res. 2019 Jun;39(6):3191-3195. doi: 10.21873/anticanres.13457.

PMID:
31177166
6.

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M.

Cancer Chemother Pharmacol. 2019 May 21. doi: 10.1007/s00280-019-03874-7. [Epub ahead of print]

PMID:
31115605
7.

Primary Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer in Asia: Unique or Not?

Shiota M.

J Natl Compr Canc Netw. 2019 May 1;17(5):523-524. doi: 10.6004/jnccn.2019.7302. No abstract available.

PMID:
31085760
8.

Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy.

Shiota M, Ushijima M, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Eto M.

Prostate. 2019 Jul;79(10):1147-1155. doi: 10.1002/pros.23828. Epub 2019 May 11.

PMID:
31077419
9.

Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.

Fujimoto N, Shiota M, Tomisaki I, Minato A, Yahara K.

Urol Int. 2019 Apr 30:1-12. doi: 10.1159/000497280. [Epub ahead of print] Review.

10.

Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men.

Shiota M, Fujimoto N, Tsukahara S, Ushijima M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Eto M.

Clin Genitourin Cancer. 2019 Jun;17(3):e387-e393. doi: 10.1016/j.clgc.2019.03.021. Epub 2019 Apr 6.

PMID:
31036465
11.

Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.

Pannala VR, Vinnakota KC, Rawls KD, Estes SK, O'Brien TP, Printz RL, Papin JA, Reifman J, Shiota M, Young JD, Wallqvist A.

Toxicol Appl Pharmacol. 2019 Jun 1;372:19-32. doi: 10.1016/j.taap.2019.04.001. Epub 2019 Apr 8.

PMID:
30974156
12.

A Study on the Incidence and Comorbidities of Autism Spectrum Disorders Accompanied by Intellectual Disabilities in Yonago City, Japan.

Nomura K, Yamaguchi M, Yokoyama M, Shiota M, Ohno K, Maegaki Y.

Yonago Acta Med. 2019 Mar 28;62(1):8-13. eCollection 2019 Mar.

13.

Network Modeling of Liver Metabolism to Predict Plasma Metabolite Changes During Short-Term Fasting in the Laboratory Rat.

Vinnakota KC, Pannala VR, Wall ML, Rahim M, Estes SK, Trenary I, O'Brien TP, Printz RL, Reifman J, Shiota M, Young JD, Wallqvist A.

Front Physiol. 2019 Mar 1;10:161. doi: 10.3389/fphys.2019.00161. eCollection 2019.

14.

Ethnic variation in gratitude and well-being.

Corona K, Senft N, Campos B, Chen C, Shiota M, Chentsova-Dutton YE.

Emotion. 2019 Mar 14. doi: 10.1037/emo0000582. [Epub ahead of print]

PMID:
30869943
15.

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men.

Shiota M, Fujimoto N, Tsukahara S, Ushijima M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Eto M.

Cancer Chemother Pharmacol. 2019 May;83(5):933-938. doi: 10.1007/s00280-019-03811-8. Epub 2019 Mar 13.

PMID:
30868236
16.

Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M.

Med Oncol. 2019 Feb 28;36(4):32. doi: 10.1007/s12032-019-1257-1.

PMID:
30815799
17.

The Effect of Dissociated Soft Tissue on Osteogenesis: A Preliminary In Vitro Study.

Kawakami S, Shiota M, Kon K, Shimogishi M, Kasugai S.

Int J Oral Maxillofac Implants. 2019 May/June;34(3):651–657. doi: 10.11607/jomi.7021. Epub 2019 Feb 26.

PMID:
30807626
18.

Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone.

Shiota M, Narita S, Akamatsu S, Fujimoto N, Sumiyoshi T, Fujiwara M, Uchiumi T, Habuchi T, Ogawa O, Eto M.

JAMA Netw Open. 2019 Feb 1;2(2):e190115. doi: 10.1001/jamanetworkopen.2019.0115.

19.

Primary non-gestational uterine choriocarcinoma mimicking leiomyoma.

Sano R, Moriya T, Suzuki S, Saito W, Shimoya K, Shiota M.

Pathol Int. 2019 Mar;69(3):160-164. doi: 10.1111/pin.12763. Epub 2019 Feb 18. Review.

PMID:
30775828
20.

KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.

Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, Teishima J, Shiota M, Matsubara A, Yasui W.

J Clin Med. 2019 Feb 9;8(2). pii: E225. doi: 10.3390/jcm8020225.

21.

Responding to the emotions of others: Age differences in facial expressions and age-specific associations with relational connectedness.

Lwi SJ, Haase CM, Shiota MN, Newton SL, Levenson RW.

Emotion. 2019 Feb 7. doi: 10.1037/emo0000534. [Epub ahead of print]

PMID:
30730167
22.

[Outcomes of Anal Squamous Cell Carcinoma Treated with Chemoradiotherapy].

Sato H, Koide Y, Shiota M, Mizuno M, Morise Z, Uyama I.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1907-1909. Japanese.

PMID:
30692394
23.

A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.

Yamaguchi T, Watanabe A, Tanaka M, Shiota M, Osada-Oka M, Sano S, Yoshiyama M, Miura K, Kitajima S, Matsunaga S, Tomita S, Iwao H, Izumi Y.

J Pharmacol Sci. 2019 Feb;139(2):112-119. doi: 10.1016/j.jphs.2018.12.004. Epub 2018 Dec 18.

24.

Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle.

Maki T, Kajioka S, Itsumi M, Kareman E, Lee K, Shiota M, Eto M.

Low Urin Tract Symptoms. 2019 Apr;11(2):O209-O217. doi: 10.1111/luts.12247. Epub 2019 Jan 10.

PMID:
30632283
25.

Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy.

Shiota M, Fujimoto N, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M.

Front Oncol. 2018 Dec 18;8:635. doi: 10.3389/fonc.2018.00635. eCollection 2018.

26.

Glutamate-oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux.

Egnatchik RA, Leamy AK, Sacco SA, Cheah YE, Shiota M, Young JD.

J Biol Chem. 2019 Mar 1;294(9):3081-3090. doi: 10.1074/jbc.RA118.004869. Epub 2018 Dec 18.

PMID:
30563841
27.

Peripheral Mechanisms Mediating the Sustained Antidiabetic Action of FGF1 in the Brain.

Scarlett JM, Muta K, Brown JM, Rojas JM, Matsen ME, Acharya NK, Secher A, Ingvorsen C, Jorgensen R, Høeg-Jensen T, Stefanovski D, Bergman RN, Piccinini F, Kaiyala KJ, Shiota M, Morton GJ, Schwartz MW.

Diabetes. 2019 Mar;68(3):654-664. doi: 10.2337/db18-0498. Epub 2018 Dec 6.

PMID:
30523024
28.

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer.

Shiota M, Namitome R, Kobayashi T, Inokuchi J, Tatsugami K, Eto M.

Int J Urol. 2019 Mar;26(3):426-428. doi: 10.1111/iju.13870. Epub 2018 Nov 21. No abstract available.

PMID:
30461081
29.

Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and Kidney.

Schyman P, Printz RL, Estes SK, Boyd KL, Shiota M, Wallqvist A.

Front Pharmacol. 2018 Nov 6;9:1272. doi: 10.3389/fphar.2018.01272. eCollection 2018.

30.

Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer.

Shiota M, Kashiwagi E, Murakami T, Takeuchi A, Imada K, Inokuchi J, Tatsugami K, Eto M.

Urol Oncol. 2019 Mar;37(3):180.e19-180.e24. doi: 10.1016/j.urolonc.2018.10.020. Epub 2018 Nov 13.

PMID:
30446464
31.

The Diabetes Susceptibility Gene SLC30A8 that Encodes the Zinc Transporter ZnT8 is a Pseudogene in Guinea Pigs Potentially Contributing to Low Guinea Pig Islet Zinc Content.

Syring KE, Bosma KJ, Oeser JK, Shiota M, O'Brien RM.

J Mol Evol. 2018 Dec;86(9):613-617. doi: 10.1007/s00239-018-9873-5. Epub 2018 Nov 3.

PMID:
30392157
32.

Does local infiltration anesthesia on laparoscopic surgical wounds reduce postoperative pain? Randomized control study.

Sugihara M, Miyake T, Miyagi Y, Oda T, Hazama Y, Sano R, Nakamura T, Shiota M, Shimoya K.

Reprod Med Biol. 2018 Aug 16;17(4):474-480. doi: 10.1002/rmb2.12224. eCollection 2018 Oct.

33.

Group 2 ITI Consensus Report: Prosthodontics and implant dentistry.

Morton D, Gallucci G, Lin WS, Pjetursson B, Polido W, Roehling S, Sailer I, Aghaloo T, Albera H, Bohner L, Braut V, Buser D, Chen S, Dawson A, Eckert S, Gahlert M, Hamilton A, Jaffin R, Jarry C, Karayazgan B, Laine J, Martin W, Rahman L, Schlegel A, Shiota M, Stilwell C, Vorster C, Zembic A, Zhou W.

Clin Oral Implants Res. 2018 Oct;29 Suppl 16:215-223. doi: 10.1111/clr.13298.

PMID:
30328196
34.

Clinical factors affecting perioperative outcomes in robot-assisted radical prostatectomy.

Murakami T, Otsubo S, Namitome R, Shiota M, Inokuchi J, Takeuchi A, Kashiwagi E, Tatsugami K, Eto M.

Mol Clin Oncol. 2018 Nov;9(5):575-581. doi: 10.3892/mco.2018.1718. Epub 2018 Sep 13.

35.

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone.

Akitake N, Shiota M, Obata H, Takeuchi A, Kashiwagi E, Imada K, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M.

Prostate Int. 2018 Sep;6(3):104-109. doi: 10.1016/j.prnil.2017.10.002. Epub 2017 Nov 21.

36.

Generation of Rat Monoclonal Antibodies Against a Deubiquitinase, Ovarian Tumor Domain-Containing Protein 1.

Oikawa D, Shiota M, Goto E, Komakura K, Wanibuchi H, Tokunaga F.

Monoclon Antib Immunodiagn Immunother. 2018 Aug;37(4):180-184. doi: 10.1089/mab.2018.0023. Epub 2018 Aug 21.

PMID:
30130141
37.

Serum testosterone before and during androgen-deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer.

Shiota M, Kashiwagi E, Murakami T, Takeuchi A, Imada K, Inokuchi J, Tatsugami K, Eto M.

Andrologia. 2018 Dec;50(10):e13119. doi: 10.1111/and.13119. Epub 2018 Aug 7.

PMID:
30084497
38.

Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat.

Pannala VR, Wall ML, Estes SK, Trenary I, O'Brien TP, Printz RL, Vinnakota KC, Reifman J, Shiota M, Young JD, Wallqvist A.

Sci Rep. 2018 Aug 3;8(1):11678. doi: 10.1038/s41598-018-30149-7.

39.

Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants.

Shiota M, Dejima T, Yamamoto Y, Takeuchi A, Imada K, Kashiwagi E, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M.

Cancer Sci. 2018 Oct;109(10):3224-3234. doi: 10.1111/cas.13751. Epub 2018 Aug 28.

40.

Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate Cancer.

Murakami T, Obata H, Akitake N, Shiota M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Eto M.

Anticancer Res. 2018 Jul;38(7):4115-4121. doi: 10.21873/anticanres.12702.

PMID:
29970538
41.

Nanostructured Fat Crystal and Solid Fat Content Effects on the Physical Properties of Water-in-Oil Semisolid Fat Blends.

Shiota M, Kamigaki T, Wakui R, Ito Y, Nishino Y, Miyazawa A.

J Oleo Sci. 2018;67(7):829-837. doi: 10.5650/jos.ess17205.

42.

MCAW-DB: A glycan profile database capturing the ambiguity of glycan recognition patterns.

Hosoda M, Takahashi Y, Shiota M, Shinmachi D, Inomoto R, Higashimoto S, Aoki-Kinoshita KF.

Carbohydr Res. 2018 Jul 15;464:44-56. doi: 10.1016/j.carres.2018.05.003. Epub 2018 May 11.

43.

Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide.

Shiota M, Fujimoto N, Higashijima K, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M.

Prostate. 2018 May 30. doi: 10.1002/pros.23661. [Epub ahead of print]

PMID:
29851126
44.

Generation of Rat Monoclonal Antibodies Specific for DZIP3.

Oikawa D, Shiota M, Tokunaga F, Wanibuchi H.

Monoclon Antib Immunodiagn Immunother. 2018 Jun;37(3):153-157. doi: 10.1089/mab.2018.0005. Epub 2018 May 29.

PMID:
29812999
45.

Metyrapone-responsive ectopic ACTH-secreting pheochromocytoma with a vicious cycle via a glucocorticoid-driven positive-feedback mechanism.

Inoue M, Okamura K, Kitaoka C, Kinoshita F, Namitome R, Nakamura U, Shiota M, Goto K, Ohtsubo T, Matsumura K, Oda Y, Eto M, Kitazono T.

Endocr J. 2018 Jul 28;65(7):755-767. doi: 10.1507/endocrj.EJ18-0025. Epub 2018 May 15.

46.

A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.

Akitake M, Kiyoshima K, Yokomizo A, Shiga K, Koga H, Takeuchi A, Shiota M, Inokuchi J, Tatsugami K, Yamaguchi A, Eto M.

Mol Clin Oncol. 2018 Jun;8(6):785-790. doi: 10.3892/mco.2018.1602. Epub 2018 Apr 2.

47.

Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival.

Shiota M, Naya M, Yamamoto T, Hishiki T, Tani T, Takahashi H, Kubo A, Koike D, Itoh M, Ohmura M, Kabe Y, Sugiura Y, Hiraoka N, Morikawa T, Takubo K, Suina K, Nagashima H, Sampetrean O, Nagano O, Saya H, Yamazoe S, Watanabe H, Suematsu M.

Nat Commun. 2018 Apr 19;9(1):1561. doi: 10.1038/s41467-018-03899-1.

48.

Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day.

Moore MC, Smith MS, Farmer B, Coate KC, Kraft G, Shiota M, Williams PE, Cherrington AD.

Diabetes. 2018 Jul;67(7):1237-1245. doi: 10.2337/db17-0979. Epub 2018 Apr 17.

49.

[Results of Neoadjuvant Chemoradiotherapy for Rectal Cancer with Invasion to the Adjacent Organs].

Sato H, Koide Y, Shiota M, Mizuno M, Morise Z, Uyama I.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1601-1603. Japanese.

PMID:
29394715
50.

Genome-wide gene expression changes associated with exposure of rat liver, heart, and kidney cells to endosulfan.

Liu R, Printz RL, Jenkins EC, O'Brien TP, Te JA, Shiota M, Wallqvist A.

Toxicol In Vitro. 2018 Apr;48:244-254. doi: 10.1016/j.tiv.2018.01.022. Epub 2018 Jan 31.

PMID:
29391264

Supplemental Content

Loading ...
Support Center